Date:March 09, 2026
Bio Usawa celebrates the extraordinary vision and leadership of the African Diaspora Network (ADN) and expresses deep appreciation for this year’s African Diaspora Investment Symposium (ADIS) organizers.
For more than a decade, ADN has built a powerful platform that elevates African innovators, strengthens connections across the global diaspora, and inspires bold action for inclusive prosperity.
At the center of this impact is the remarkable leadership of Almaz Negash, whose unwavering commitment to mobilizing diaspora talent, capital, and community has transformed ADN into a global force for good.
Her work continues to shape ecosystems, open doors, and accelerate opportunities that benefit millions across Africa and its global diaspora.
In the first half of 2026, Bio Usawa will open Sub-Saharan Africa’s first GMP-compliant monoclonal antibodies manufacturing facility in Rwanda — a histo…
March 2026Bio Usawa was honored to be received by Dr. Ivan Butera, Rwanda’s Minister of State for Health, this week to share updates on the company's progress and…
March 2026Bio Usawa, a leader in expanding global access to biopharmaceuticals, and Nanoly Bioscience, a pioneer in chemical stabilization, today announced a defi…
February 2026